はじめての方へショーケース価格
  1. 米国企業
  2. bluebird bio, Inc.

bluebird bio, Inc.BLUE

時価総額
$1.1億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日
Product revenue--------33
Other revenue--------11
Total revenues202514635554525144
Research and development3163134205273449582588320241
Selling, general and administrative------271287210137
Product revenue--------3910
Cost of product revenue-----135--
Restructuring expense--------265
Total operating expenses4586----860874595393
Gain (Loss) on Disposition of Assets---------102
Loss from operations-25-61-169-268-332-572-815-623-591-287
Interest income, net-----215351211
Other income (expense), net-0-14-12-10-72820
Loss before income taxes--61-167-264-335-555-790-618-562-266
Income tax (expense) benefit--120-100-1100
Net loss from continuing operations---------563-267
Net loss from discontinued operations---------257-
Net loss-25-49-167-264-336-556-790-619-819-267
Income (Loss) from Continuing Operations, Per Basic Share---------8.16-3.39
Income (Loss) from Continuing Operations, Per Diluted Share---------8.16-3.39
Net loss per share from discontinued operations - basic (in dollars per share)---------3.73-
Net loss per share from discontinued operations - diluted (in dollars per share)---------3.73-
Net loss per share applicable to common stockholders - basic (in dollars per share)---------11.89-3.39
Net loss per share applicable to common stockholders - diluted (in dollars per share)---------11.89-3.39
Other comprehensive income (loss)--0-21-312-42-1
Comprehensive loss-25-49-169-262-339-555-788-622-817-268